GlassScriptPhysician profile
Amanda Macquoid
NPI 1194284174
$3,956.20
in general payments reported to CMS, 2019-2025
12 companies · $1,574 in 2025
The $1,574 reported for 2025 was more than what 76% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $261 · 2023: $1,616 · 2024: $505 · 2025: $1,574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856 · Education: $1,000 · Travel and Lodging: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.81 |
| Education | $1,000.00 |
| Travel and Lodging | $838.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,051.61 | 2023-2024 | Davinci Xi |
| Zimmer Biomet Holdings, INC. | $917.79 | 2025 | Ribfix Titan, Advantagerib |
| Kerecis Limited | $483.59 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Teleflex LLC | $445.51 | 2023-2025 | Quikclot, Quikclot |
| Polynovo North America LLC | $209.21 | 2025 | Novosorb Btm |
| Avita Medical Americas, LLC | $138.27 | 2024 | |
| Baxter Healthcare | $136.61 | 2024 | Starling System |
| Cook Medical LLC | $134.74 | 2022 | |
| Acera Surgical, INC. | $126.74 | 2022 | |
| Hemosonics LLC | $118.07 | 2023 | Quantra Qplus System |
| Medical Device Business Services, INC. | $116.78 | 2025 | Surgicel Nu-Knit |
| Astrazeneca Pharmaceuticals LP | $77.28 | 2024 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Macquoid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.